Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
PCAR-019 (anti-CD19 CAR-T cells)
Locations
1
China
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Suzhou, Jiangsu, China
Start Date
July 1, 2016
Primary Completion Date
November 1, 2018
Completion Date
November 1, 2019
Last Updated
August 1, 2016
NCT06337318
NCT05006716
NCT07277231
NCT06859424
NCT06026319
NCT06481735
Lead Sponsor
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions